Please login to the form below

Not currently logged in
Email:
Password:

Merck (MSD) expands South African business

Merck (MSD) has entered into a collaboration with Adcock Ingram to co-promote and distribute a number of products in the South African market

Merck (MSD) has entered into strategic collaboration deal with South African company Adcock Ingram. The two companies will co-promote and distribute a selection of prescription products across a number of therapy areas including: asthma, dermatology, hypercholesterolemia, hypertension, migraine and osteoporosis. A number of over-the-counter (OTC) products will also be included in the deal. All of the products are currently registered in South Africa by MSD and Schering-Plough.

Financial details of the deal were not disclosed.

Dr Stefan Oschmann, president, Emerging Markets, MSD said: "We expect sales from these [emerging] markets to be a key contributor to our future performance and growth. As part of our pursuit of that growth we will strive to expand our presence across emerging markets by actively seeking local collaborations." 

Merck expects more than 25 per cent of its global pharmaceutical and vaccine revenue in 2013 to come from emerging markets. The company is the second biggest pharmaceutical company (by revenue) in the world. Its key products include the cholesterol drugs Vytorin (ezetimibe and simvastatin) and Zetia (ezetimibe), and the asthma therapy Singulair (montelukast sodium).

Merck is known as MSD outside of the US and Canada.

24th June 2010

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

Live webinar:
The power of a good story: Turn your insights into effective storytelling with data visualisation...
clinical research org
The important role of CROs in shaping the future of clinical research across Europe
Looking at the impact of COVID-19 on clinical research activities...
What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...

Infographics